Clinical Practice Guidelines, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/cqf-recommendations/ and changes regularly. See the Directory of published versions
Official URL: http://hl7.org/fhir/uv/cpg/ActivityDefinition/chf-lasix-po | Version: 2.0.0 | |||
Active as of 2024-11-26 | Computable Name: CHFLASIXPO | |||
Other Identifiers: OID:2.16.840.1.113883.4.642.40.48.11.29 |
Activity definition to administer LASIX PO as part of a congestive heart failure pathway
Generated Narrative: ActivityDefinition chf-lasix-po
CQF Knowledge capability: shareable
CQF Knowledge capability: computable
CQF Knowledge capability: publishable
url: ActivityDefinition CHFLASIXPO
identifier: Uniform Resource Identifier (URI)/urn:oid:2.16.840.1.113883.4.642.40.48.11.29
version: 2.0.0
name: CHFLASIXPO
status: Active
experimental: true
date: 2024-11-26 06:42:34+0000
publisher: HL7 International / Clinical Decision Support
contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss
description:
Activity definition to administer LASIX PO as part of a congestive heart failure pathway
jurisdiction: World
kind: MedicationRequest
profile: CPG Medication Request
code: Order a medication
intent: Proposal
priority: Routine
doNotPerform: false
product: LASIX PO
dosage
sequence: 1
text: 40mg
timing: Once per 1 days
route: Oral Route (qualifier value)
DoseAndRates
Type Dose[x] Ordered 40 mg (Details: UCUM codemg = 'mg')